Literature DB >> 15960718

The management of accidental dural puncture during labour epidural analgesia: a survey of UK practice.

R Baraz1, R E Collis.   

Abstract

The management of accidental dural puncture and postdural puncture headache in obstetric practice continues to be of great interest. This survey aims to explore the current management of this complication in the United Kingdom and compares the findings to a similar survey undertaken in 1993. A postal questionnaire was sent to all maternity units (n = 248). The return rate was 71%. Of these, 144 units (85%) now have written guidelines for the management of accidental dural puncture compared to 58% in 1993. In 47 units (28%), the epidural catheter is now routinely placed intrathecally following accidental dural puncture; in 69 units (41%) the catheter is re-sited and in the remaining 53 units (31%) either option is allowed. This is in contrast to the previous survey, which found that catheters were re-sited in 99% of units. Only 31 units (18%) now limit the second stage of labour and 19 (11%) avoid pushing and deliver by ventouse or forceps, whilst 116 units (69%) allow labour to take place without any intervention. Only 44 units (26%) now treat postdural puncture headache with an epidural blood patch as soon as it is diagnosed, whereas in 120 units (71%) the blood patch is performed only after failure of conservative measures. Due to the large increase in the use of the intrathecal catheter following this complication, a follow-up questionnaire was posted 5 months later to those units (n = 99) that reported this practice in the initial survey, with a 94% response rate. The two most commonly cited reasons for intrathecal catheterisation were to avoid further dural puncture (76%) and to allow immediate analgesia for labour (75%).

Entities:  

Mesh:

Year:  2005        PMID: 15960718     DOI: 10.1111/j.1365-2044.2005.04222.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  8 in total

1.  Pre-puncture ultrasound guided epidural insertion before vaginal delivery.

Authors:  Mahmoud Nassar; Ibrahim A Abdelazim
Journal:  J Clin Monit Comput       Date:  2014-10-28       Impact factor: 2.502

2.  Continuous spinal anesthesia in a high risk elderly patient using epidural set.

Authors:  Meenu Goyal; Susheela Taxak; Kirti Kamal Kshetrapal; Manish Kumar Goel
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

3.  Intrathecal catheterization after unintentional dural puncture during orthopedic surgery.

Authors:  Ayda Turkoz; Aysu Kocum; H Evren Eker; Hacer Ulgen; Mustafa Uysalel; Gulnaz Arslan
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

4.  Intrathecal Catheterization by Epidural Catheter: Management of Accidental Dural Puncture and Prophylaxis of PDPH.

Authors:  Ashok Jadon; Swastika Chakraborty; Neelam Sinha; Rajiv Agrawal
Journal:  Indian J Anaesth       Date:  2009-02

5.  Accidental dural puncture, postdural puncture headache, intrathecal catheters, and epidural blood patch: revisiting the old nemesis.

Authors:  Roland Kaddoum; Faisal Motlani; Romeo N Kaddoum; Arvi Srirajakalidindi; Deepak Gupta; Vitaly Soskin
Journal:  J Anesth       Date:  2013-12-18       Impact factor: 2.078

6.  Utilization of Obstetric Analgesia for Labor Pain Management and Associated Factors among Obstetric Care Providers in Public Hospitals of Addis Ababa, Ethiopia: A Cross-Sectional Study.

Authors:  Rediet Gido; Tesfaye Assebe Yadeta; Abera Kenay Tura
Journal:  Obstet Gynecol Int       Date:  2021-11-22

Review 7.  Continuous Spinal Anesthesia for Obstetric Anesthesia and Analgesia.

Authors:  Ivan Veličković; Borislava Pujic; Charles W Baysinger; Curtis L Baysinger
Journal:  Front Med (Lausanne)       Date:  2017-08-15

8.  Insertion of an intrathecal catheter in parturients reduces the risk of post-dural puncture headache: A retrospective study and meta-analysis.

Authors:  Jiali Deng; Lizhong Wang; Yinfa Zhang; Xiangyang Chang; Xingjie Ma
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.